Scintigraphic liver function and transient elastography in the assessment of patients with resectable hepatocellular carcinoma.


Journal

HPB : the official journal of the International Hepato Pancreato Biliary Association
ISSN: 1477-2574
Titre abrégé: HPB (Oxford)
Pays: England
ID NLM: 100900921

Informations de publication

Date de publication:
05 2019
Historique:
received: 09 04 2018
revised: 16 09 2018
accepted: 27 09 2018
pubmed: 28 10 2018
medline: 9 4 2020
entrez: 28 10 2018
Statut: ppublish

Résumé

Hepatobiliary scintigraphy (HBS) is used to quantify total and regional liver function. Transient elastography (TE) provides a non-invasive alternative to percutaneous biopsy to assess liver fibrosis and cirrhosis. This study aims to determine the correlation between HBS and histopathology of liver parenchyma, and to compare these with TE in patients with resectable hepatocellular carcinoma (HCC). Patients who underwent surgery for HCC between 2000 and 2016 after preoperative HBS were included. Non-tumorous liver tissue was evaluated for inflammation, steatosis, ballooning, siderosis and fibrosis. Correlation analysis was performed between HBS results and histopathological scoring. These were also compared with TE and surgical outcomes. 71 patients underwent preoperative HBS of whom 24 also had TE. HBS correlated with portal and lobular inflammation as well as fibrosis. TE correlated with portal and lobular inflammation, ballooning and fibrosis. A significant correlation was found between HBS and TE. No association was found with overall postoperative morbidity and mortality. HBS and TE show a moderate to strong correlation. HBS and TE share discriminatory features of histopathological scoring and show a weak to moderate correlation with hepatic inflammation and fibrosis.

Sections du résumé

BACKGROUND
Hepatobiliary scintigraphy (HBS) is used to quantify total and regional liver function. Transient elastography (TE) provides a non-invasive alternative to percutaneous biopsy to assess liver fibrosis and cirrhosis. This study aims to determine the correlation between HBS and histopathology of liver parenchyma, and to compare these with TE in patients with resectable hepatocellular carcinoma (HCC).
METHODS
Patients who underwent surgery for HCC between 2000 and 2016 after preoperative HBS were included. Non-tumorous liver tissue was evaluated for inflammation, steatosis, ballooning, siderosis and fibrosis. Correlation analysis was performed between HBS results and histopathological scoring. These were also compared with TE and surgical outcomes.
RESULTS
71 patients underwent preoperative HBS of whom 24 also had TE. HBS correlated with portal and lobular inflammation as well as fibrosis. TE correlated with portal and lobular inflammation, ballooning and fibrosis. A significant correlation was found between HBS and TE. No association was found with overall postoperative morbidity and mortality.
CONCLUSION
HBS and TE show a moderate to strong correlation. HBS and TE share discriminatory features of histopathological scoring and show a weak to moderate correlation with hepatic inflammation and fibrosis.

Identifiants

pubmed: 30366883
pii: S1365-182X(18)34471-X
doi: 10.1016/j.hpb.2018.09.021
pii:
doi:

Substances chimiques

Aniline Compounds 0
Imino Acids 0
Organotechnetium Compounds 0
Radiopharmaceuticals 0
technetium Tc 99m mebrofenin F2NQ468L52
Glycine TE7660XO1C

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

626-635

Informations de copyright

Copyright © 2018 International Hepato-Pancreato-Biliary Association Inc. Published by Elsevier Ltd. All rights reserved.

Auteurs

Fadi Rassam (F)

Department of Surgery, Amsterdam UMC, University of Amsterdam, the Netherlands. Electronic address: f.rassam@amc.uva.nl.

Pim B Olthof (PB)

Department of Surgery, Amsterdam UMC, University of Amsterdam, the Netherlands; Department of Surgery, Reinier de Graaf Gasthuis, Delft, the Netherlands.

Bart R Takkenberg (BR)

Department of Gastroenterology and Hepatology, Amsterdam UMC, University of Amsterdam, the Netherlands.

Ulrich Beuers (U)

Department of Gastroenterology and Hepatology, Amsterdam UMC, University of Amsterdam, the Netherlands.

Heinz-Josef Klümpen (HJ)

Department of Medical Oncology, Amsterdam UMC, University of Amsterdam, the Netherlands.

Roelof J Bennink (RJ)

Department of Radiology and Nuclear Medicine, Amsterdam UMC, University of Amsterdam, the Netherlands.

Krijn P van Lienden (KP)

Department of Radiology and Nuclear Medicine, Amsterdam UMC, University of Amsterdam, the Netherlands.

Marc G Besselink (MG)

Department of Surgery, Amsterdam UMC, University of Amsterdam, the Netherlands.

Olivier R Busch (OR)

Department of Surgery, Amsterdam UMC, University of Amsterdam, the Netherlands.

Joanne Verheij (J)

Department of Pathology, Amsterdam UMC, University of Amsterdam, the Netherlands.

Thomas M van Gulik (TM)

Department of Surgery, Amsterdam UMC, University of Amsterdam, the Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH